116 related articles for article (PubMed ID: 3155494)
1. Enzyme activities in prostatic carcinoma related to Gleason grades.
Pretlow TG; Harris BE; Bradley EL; Bueschen AJ; Lloyd KL; Pretlow TP
Cancer Res; 1985 Jan; 45(1):442-6. PubMed ID: 3155494
[TBL] [Abstract][Full Text] [Related]
2. Arginase activity in prostatic tissue of patients with benign prostatic hyperplasia and prostatic carcinoma.
Harris BE; Pretlow TP; Bradley EL; Whitehurst GB; Pretlow TG
Cancer Res; 1983 Jun; 43(6):3008-12. PubMed ID: 6189588
[TBL] [Abstract][Full Text] [Related]
3. Decrease in creatine kinase in human prostatic carcinoma compared to benign prostatic hyperplasia.
Pretlow TG; Whitehurst GB; Pretlow TP; Hunt RS; Jacobs JM; McKenzie DR; McDaniel HG; Hall LM; Bradley EL
Cancer Res; 1982 Nov; 42(11):4842-8. PubMed ID: 6181869
[TBL] [Abstract][Full Text] [Related]
4. Possible implications of arginase and diamine oxidase in prostatic carcinoma.
Keskinege A; Elgün S; Yilmaz E
Cancer Detect Prev; 2001; 25(1):76-9. PubMed ID: 11270424
[TBL] [Abstract][Full Text] [Related]
5. 5'-nucleotidase activity in prostatic carcinoma and benign prostatic hyperplasia.
Rackley RR; Lewis TJ; Preston EM; Delmoro CM; Bradley EL; Resnick MI; Pretlow TP; Pretlow TG
Cancer Res; 1989 Jul; 49(13):3702-7. PubMed ID: 2471588
[TBL] [Abstract][Full Text] [Related]
6. Prediction of pelvic lymph node metastasis by the ratio of cathepsin B to stefin A in patients with prostate carcinoma.
Sinha AA; Quast BJ; Wilson MJ; Fernandes ET; Reddy PK; Ewing SL; Gleason DF
Cancer; 2002 Jun; 94(12):3141-9. PubMed ID: 12115346
[TBL] [Abstract][Full Text] [Related]
7. Enzymatic activities in extracts of small (20 +/- 5 mg) samples of prostatic carcinoma.
Rackley RR; Lewis TJ; Bradley EL; Levin HS; Resnick MI; Pretlow TP; Pretlow TG
Anal Biochem; 1990 Jan; 184(1):128-34. PubMed ID: 1690957
[TBL] [Abstract][Full Text] [Related]
8. Lack of association of prostate carcinoma nuclear grading with prostate specific antigen recurrence after radical prostatectomy.
Zhou M; Hayasaka S; Taylor JM; Shah R; Proverbs-Singh T; Manley S; Rubin MA
J Urol; 2001 Dec; 166(6):2193-7. PubMed ID: 11696734
[TBL] [Abstract][Full Text] [Related]
9. Prognostic factors for survival of patients with pathological Gleason score 7 prostate cancer: differences in outcome between primary Gleason grades 3 and 4.
Lau WK; Blute ML; Bostwick DG; Weaver AL; Sebo TJ; Zincke H
J Urol; 2001 Nov; 166(5):1692-7. PubMed ID: 11586204
[TBL] [Abstract][Full Text] [Related]
10. Tertiary Gleason pattern 5 is a powerful predictor of biochemical relapse in patients with Gleason score 7 prostatic adenocarcinoma.
Hattab EM; Koch MO; Eble JN; Lin H; Cheng L
J Urol; 2006 May; 175(5):1695-9; discussion 1699. PubMed ID: 16600733
[TBL] [Abstract][Full Text] [Related]
11. Alpha-methylacyl-CoA racemase (P504S) expression in evolving carcinomas within benign prostatic hyperplasia and in cancers of the transition zone.
Leav I; McNeal JE; Ho SM; Jiang Z
Hum Pathol; 2003 Mar; 34(3):228-33. PubMed ID: 12673556
[TBL] [Abstract][Full Text] [Related]
12. Prostatic hexosaminidase activity in patients with benign prostatic hyperplasia and prostatic carcinoma.
Whitehurst GB; Mashburn JP; Pretlow TG; Bradley EL; Boohaker EA
Cancer Res; 1982 Oct; 42(10):4300-3. PubMed ID: 6179600
[TBL] [Abstract][Full Text] [Related]
13. [Correlation between histologic grading and prognosis of prostatic cancer--comparing the grading system of the Japanese general rules of prostatic cancer with Gleason's grading].
Hioki T; Sugimura Y; Sakurai M; Hayashi N; Tochigi H; Kawamura J; Yatani R
Hinyokika Kiyo; 1990 Aug; 36(8):921-6. PubMed ID: 2239593
[TBL] [Abstract][Full Text] [Related]
14. High-grade foamy gland prostatic adenocarcinoma on biopsy or transurethral resection: a morphologic study of 55 cases.
Zhao J; Epstein JI
Am J Surg Pathol; 2009 Apr; 33(4):583-90. PubMed ID: 19033862
[TBL] [Abstract][Full Text] [Related]
15. Trends in distribution and prognostic significance of Gleason grades on radical retropubic prostatectomy specimens between 1989 and 2001.
Sengupta S; Slezak JM; Blute ML; Leibovich BC; Sebo TJ; Myers RP; Cheville JC; Bergstralh EJ; Zincke H
Cancer; 2006 Jun; 106(12):2630-5. PubMed ID: 16703592
[TBL] [Abstract][Full Text] [Related]
16. Heterogeneity of Gleason grade in multifocal adenocarcinoma of the prostate.
Arora R; Koch MO; Eble JN; Ulbright TM; Li L; Cheng L
Cancer; 2004 Jun; 100(11):2362-6. PubMed ID: 15160339
[TBL] [Abstract][Full Text] [Related]
17. Percent Gleason grade 4/5 as prognostic factor in prostate cancer diagnosed at transurethral resection.
Egevad L; Granfors T; Karlberg L; Bergh A; Stattin P
J Urol; 2002 Aug; 168(2):509-13. PubMed ID: 12131299
[TBL] [Abstract][Full Text] [Related]
18. [Correlation between histological grading and the prognosis of prostatic carcinoma--a comparative study of the Japanese General Rules of Prostatic Cancer (JGRPC) and Gleason's classification].
Uchida T; Go M; Nakajo H; Takagi Y; Murayama M; Honda N; Igarashi M; Ishibashi A; Koshiba K
Hinyokika Kiyo; 1988 Jan; 34(1):116-22. PubMed ID: 3376792
[TBL] [Abstract][Full Text] [Related]
19. [Reproducibility and prognostic value of Gleason's and Gaeta's histological grades in prostatic carcinoma].
Rousselet MC; Saint-André JP; Six P; Soret JY
Ann Urol (Paris); 1986; 20(5):317-22. PubMed ID: 3777875
[TBL] [Abstract][Full Text] [Related]
20. A comprehensive and novel predictive modeling technique using detailed pathology factors in men with localized prostate carcinoma.
Potters L; Purrazzella R; Brustein S; Fearn P; Leibel SA; Kattan MW
Cancer; 2002 Oct; 95(7):1451-6. PubMed ID: 12237913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
